| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| May 21, 2025 | May 22, 2025 | Oncology Institute, Inc. | CEO | Sell | 42.5 | -20,388 | -1.13% | ✗ | $54.5K |
| Mar 26, 2025 | Mar 28, 2025 | Oncology Institute, Inc. | CEO | Buy | 83.8 | +22,640 | 3.23% | ✗ | $23.6K |
| Mar 19, 2025 | Mar 20, 2025 | Oncology Institute, Inc. | CEO | Sell | 47.5 | -10,261 | -1.44% | ✗ | $9.1K |
| Nov 20, 2024 | Nov 21, 2024 | Oncology Institute, Inc. | CEO | Sell | 47.5 | -9,727 | -1.35% | ✗ | $1.3K |
| May 21, 2024 | May 23, 2024 | Oncology Institute, Inc. | CEO | Sell | 90.0 | +187,344 | 25.68% | ✗ | $6.7K |
| Nov 21, 2023 | Nov 22, 2023 | Oncology Institute, Inc. | CEO | Sell | 37.5 | -4,322 | -0.59% | ✗ | $9.5K |
| Nov 14, 2023 | Nov 16, 2023 | Oncology Institute, Inc. | CEO | Sell | 36.3 | -4,604 | -0.62% | ✗ | $11K |
| Nov 15, 2022 | Nov 22, 2022 | Oncology Institute, Inc. | President | Sell | 47.5 | -3,767 | -1.59% | ✗ | $7.6K |
| Nov 15, 2022 | Nov 17, 2022 | Oncology Institute, Inc. | President | Sell | 47.5 | -3,767 | -1.59% | ✗ | $7.6K |